0000911916-15-000143.txt : 20150505 0000911916-15-000143.hdr.sgml : 20150505 20150505173542 ACCESSION NUMBER: 0000911916-15-000143 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20150505 FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PV III CEO Fund, L.P. CENTRAL INDEX KEY: 0001573873 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 15834299 BUSINESS ADDRESS: STREET 1: C/O PAPPAS VENTURES STREET 2: PO BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 277709 BUSINESS PHONE: 919-998-3330 MAIL ADDRESS: STREET 1: C/O PAPPAS VENTURES STREET 2: PO BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 277709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: A.M. Pappas Life Science Ventures III, L.P. CENTRAL INDEX KEY: 0001573854 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 15834300 BUSINESS ADDRESS: STREET 1: C/O PAPPAS VENTURES STREET 2: PO BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 277709 BUSINESS PHONE: 919-998-3330 MAIL ADDRESS: STREET 1: C/O PAPPAS VENTURES STREET 2: PO BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 277709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: A.M. Pappas & Associates, LLC CENTRAL INDEX KEY: 0001320654 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 15834302 BUSINESS ADDRESS: STREET 1: POST OFFICE BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (919) 998-3300 MAIL ADDRESS: STREET 1: POST OFFICE BOX 110287 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPPAS ARTHUR M CENTRAL INDEX KEY: 0001189543 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 15834303 MAIL ADDRESS: STREET 1: 8995 WESTSIDE PARKWAY CITY: ALPHARETTA STATE: 2Q ZIP: 30004 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2015-05-05 0 0001348649 CoLucid Pharmaceuticals, Inc. CLCD 0001189543 PAPPAS ARTHUR M 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 1 0 1 0 0001573854 A.M. Pappas Life Science Ventures III, L.P. 2520 MERIDIAN PARKWAY, SUITE 400 DURHAM NC 27713 0 0 1 0 0001573873 PV III CEO Fund, L.P. 2520 MERIDIAN PARKWAY, SUITE 400 DURHAM NC 27713 0 0 1 0 0001320654 A.M. Pappas & Associates, LLC 2520 MERIDIAN PARKWAY, SUITE 400 DURHAM NC 27713 0 0 1 0 Common Stock 2 I By A. M. Pappas Life Science Ventures III, L.P. Common Stock 5528 I By A.M. Pappas & Associates, LLC Series A Convertible Preferred Stock Common Stock 578297 I By A. M. Pappas Life Science Ventures III, L.P. Series A Convertible Preferred Stock Common Stock 35953 I By PV III CEO Fund, L.P. Series B Convertible Preferred Stock Common Stock 675588 I By A. M. Pappas Life Science Ventures III, L.P. Series B Convertible Preferred Stock Common Stock 41996 I By PV III CEO Fund, L.P. Series C Convertible Preferred Stock Common Stock 334722 I By A. M. Pappas Life Science Ventures III, L.P. Series C Convertible Preferred Stock Common Stock 20808 I By PV III CEO Fund, L.P. Represents securities held directly by A.M. Pappas Life Science Ventures III, L.P. AMP&A Management III, LLC is the general partner of A. M. Pappas Life Science Ventures III, L.P. and has a management agreement with A. M. Pappas & Associates, LLC. As a result, A. M. Pappas & Associates, LLC's investment committee has sole power to vote or to direct the vote of, and sole power to dispose or to direct the disposition of, all shares owned A.M. Pappas Life Science Ventures III, L.P. The reporting person is the sole managing member of A. M. Pappas & Associates, LLC. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Represents securities held directly by A. M. Pappas & Associates, LLC. The reporting person is the sole managing member of A. M. Pappas & Associates, LLC. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Represents securities held directly by PV III CEO Fund, L.P. AMP&A Management III, LLC is the general partner of PV III CEO Fund, L.P. and has a management agreement with A. M. Pappas & Associates, LLC. As a result, A. M. Pappas & Associates, LLC's investment committee has sole power to vote or to direct the vote of, and sole power to dispose or to direct the disposition of, all shares owned PV III CEO Fund, L.P. The reporting person is the sole managing member of A. M. Pappas & Associates, LLC. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Each share of Series A, Series B and Series C Convertible Preferred Stock is convertible at any time at the option of the holder, and will convert automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering. The securities do not have an expiration date. The securities convert automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering. Exhibit 24 - Powers of Attorney /s/ Miranda S. Hirner, Attorney-in-Fact for Arthur M. Pappas (power of attorney filed herewith) 2015-05-05 /s/ Miranda S. Hirner, Attorney-in-Fact for A.M. Pappas Life Science Ventures III, L.P. (power of attorney filed herewith) 2015-05-05 /s/ Miranda S. Hirner, Attorney-in-Fact for PV III CEO Fund, L.P. (power of attorney filed herewith) 2015-05-05 /s/ Miranda S. Hirner, Attorney-in-Fact for A.M. Pappas & Associates, LLC (power of attorney filed herewith) 2015-05-05 EX-24 2 pappaspoa.htm POWER OF ATTORNEY - ARTHUR M. PAPPAS

POWER OF ATTORNEY



For Executing Forms 144, Forms 3, 4, 5 and Form ID



The undersigned hereby constitutes and appoints Daniel L. Boeglin,

Christine G. Long, Jonathan R. Zimmerman, Laura D. Yockey,

Kassendra D. Galindo, Miranda S. Hirner, and Tracy L. Whitman,

and each of them, the undersigned's true and lawful attorney-in-fact,

for such period of time that the undersigned is required to file

reports pursuant to Section 16(a) of the Securities Exchange Act of

1934,as amended (the "Exchange Act"), or Rule 144 of the Securities

Act of 1933, as amended (the "Securities Act"), due to the

undersigned's affiliation with CoLucid Pharmaceuticals, Inc.,

a Delaware corporation, unless earlier revoked by the undersigned

in a signed writing delivered to the foregoing attorneys-in-fact, to:



1) execute for and on behalf of the undersigned Forms 144, Forms 3,

4, 5 and Form ID and any amendments to previously filed forms in

accordance with Section 16(a) of the Exchange Act or Rule 144 of

the Securities Act and the rules thereunder;



2) do and perform any and all acts for and on behalf of the

undersigned which may be necessary or desirable to complete the

execution of any such Forms 144, Forms 3, 4, 5 and Form ID and the

timely filing of such form with the United States Securities and

Exchange Commission and any other authority as required by law; and



3) take any other action of any type whatsoever in connection with

the foregoing which, in the opinion of such attorney-in-fact, may

be of benefit to, in the best interest of or legally required by the

undersigned, it being understood that the documents executed by such

attorney-in-fact on behalf of the undersigned pursuant to this Power

of Attorney shall be in such form and shall contain such terms and

conditions as such attorney-in-fact may approve in his discretion.



The undersigned hereby grants to each such attorney-in-fact full

power and authority to do and perform all and every act and thing

whatsoever requisite, necessary and proper to be done in the

exercise of any of the rights and powers herein granted, as fully

to all intents and purposes as the undersigned could do if personally

present, with full power of substitution or revocation, hereby

ratifying and confirming all that such attorney-in-fact, or his

or her substitute or substitutes, shall lawfully do or cause to be

done by virtue of this Power of Attorney and the rights and powers

herein granted.  The undersigned acknowledges that the foregoing

attorneys-in-fact, in serving in such capacity at the request of

the undersigned, are not assuming any of the undersigned's

responsibilities to comply with Section 16 of the Exchange Act

or Rule 144 of the Securities Act.



IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this _____ day of April, 2015.



/s/ Arthur M. Pappas

(Signature)



Arthur M. Pappas

(Print Name)

EX-24 3 pappasentitiespoa.htm POWER OF ATTORNEY - A.M. PAPPAS LIFE SCIENCE VENTURES III, L.P., PV III CEO FUND, L.P. AND A.M. PAPPAS & ASSOCIATES, LLC

A.M. PAPPAS LIFE SCIENCE VENTURES III, L.P.

PV III CEO FUND, L.P.

A.M. PAPPAS & ASSOCIATES, LLC



POWER OF ATTORNEY



For Executing Forms 144, Forms 3, 4, 5 and Form ID



Each of the undersigned, including (i) A.M. Pappas Life

Science Ventures III, L.P.; (ii) PV III CEO Fund, L.P.;

and (iii) A.M. Pappas & Associates, LLC hereby constitutes

and appoints Daniel L. Boeglin, Christine G. Long,

Jonathan R. Zimmerman, Laura D. Yockey, Kassendra D. Galindo,

Miranda S. Hirner, and Tracy L. Whitman, and each of them,

the undersigned's true and lawful attorney-in-fact,

for such period of time that the undersigned is required to file

reports pursuant to Section 16(a) of the Securities Exchange Act of

1934,as amended (the "Exchange Act"), or Rule 144 of the Securities

Act of 1933, as amended (the "Securities Act"), due to the

undersigned's affiliation with CoLucid Pharmaceuticals, Inc.,

a Delaware corporation, unless earlier revoked by the undersigned

in a signed writing delivered to the foregoing attorneys-in-fact, to:



1) execute for and on behalf of the undersigned Forms 144, Forms 3,

4, 5 and Form ID and any amendments to previously filed forms in

accordance with Section 16(a) of the Exchange Act or Rule 144 of

the Securities Act and the rules thereunder;



2) do and perform any and all acts for and on behalf of the

undersigned which may be necessary or desirable to complete the

execution of any such Forms 144, Forms 3, 4, 5 and Form ID and the

timely filing of such form with the United States Securities and

Exchange Commission and any other authority as required by law; and



3) take any other action of any type whatsoever in connection with

the foregoing which, in the opinion of such attorney-in-fact, may

be of benefit to, in the best interest of or legally required by the

undersigned, it being understood that the documents executed by such

attorney-in-fact on behalf of the undersigned pursuant to this Power

of Attorney shall be in such form and shall contain such terms and

conditions as such attorney-in-fact may approve in his discretion.



The undersigned hereby grants to each such attorney-in-fact full

power and authority to do and perform all and every act and thing

whatsoever requisite, necessary and proper to be done in the

exercise of any of the rights and powers herein granted, as fully

to all intents and purposes as the undersigned could do if personally

present, with full power of substitution or revocation, hereby

ratifying and confirming all that such attorney-in-fact, or his

or her substitute or substitutes, shall lawfully do or cause to be

done by virtue of this Power of Attorney and the rights and powers

herein granted.  The undersigned acknowledges that the foregoing

attorneys-in-fact, in serving in such capacity at the request of

the undersigned, are not assuming any of the undersigned's

responsibilities to comply with Section 16 of the Exchange Act

or Rule 144 of the Securities Act.



IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this 28th day of April, 2015.



A. M. PAPPAS LIFE SCIENCE

VENTURES III, L.P.

By: AMP&A Management III, LLC



By: /s/ Ford S. Worthy

Name: Ford S. Worthy

Title: Partner & CFO



PV III CEO FUND, L.P.

By: AMP&A Management III, LLC



By: /s/ Ford S. Worthy

Name: Ford S. Worthy

Title: Partner & CFO



A.M. PAPPAS & ASSOCIATES, LLC



By: /s/ Ford S. Worthy

Name: Ford S. Worthy

Title: Partner & CFO